Helixmith’s Plasmid DNA Therapeutic Moves Forward With New Formulation

Non-Viral Gene Therapy Set For Mass Production

DNA
DPN Phase III-2 Results Pivotal For Program Success • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from South Korea

More from Focus On Asia